glp-1 drugs and fatty liver glp 1 approved for nash Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Disease (MAFLD) glp 1 and liver Multiple

Dull, uneven skin tone can feel frustrating, especially when youre doing everything right and still not seeing that natural glow

Nat Rev Neurosci 18(7):419434 Iadecola C (2013) The pathobiology of vascular dementia

For treatment of primary systemic carnitine deficiency, a genetic impairment of normal biosynthesis or utilization of levocarnitine from dietary sources, or for the treatment of secondary carnitine deficiency resulting from an inborn error of metabolism such as glutaric aciduria II, methyl malonic aciduria, propionic acidemia, and medium chain fatty acylCoA dehydrogenase deficiency

But obesity is not a trend, and your treatment should not be based on what is hottest this quarter

This review has systematically summarized evidence suggesting that L-carnitine exerts multi-targeted actions against MASLD pathogenesis by promoting lipid metabolism, improving insulin sensitivity, stabilizing hepatocyte function, and inhibiting inflammatory and fibrotic signaling pathways